Besides, the protein levels of p-PKA and RNF2 were both significantly decreased in U87 xenografts after MDL29951 treatment, which further revealed the role of GPR17 activation in the control of PKA signaling activity and RNF2 expression in glioma (Fig. 7H). Here, GPR17 is linked to central nervous system cancer.